Collapsin response mediator protein-2 (CRMP2) is a plausible etiological factor and potential therapeutic target in Alzheimer’s disease: Comparison and contrast with microtubule-associated protein tau
Manuscript Number:
16-0076R1
Author(s):
Kenneth Hensley, Petri Kursula
Disclosures
Kenneth Hensley
Equity:
Equity position in XoNovo Inc., co-founder
Patents/Royalties
Inventor of licensed patent regarding lanthionine ketimine derivatives